Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease

Overview of attention for article published in JAMA Neurology, February 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 4 public wall posts from 4 users.

RT @JAMANeuro: In #Alzheimerdisease, #minocycline at 200mg and 400mg per day offers no advantages over placebo on cognitive and…

Minocycline at 200mg and 400mg per day offers no advantages over placebo on cognitive and functional decline over 24 months in…

This randomized clinical trial examines whether 24 months of minocycline treatment can modify cognitive and functional decline…

This randomized clinical trial examines whether 24 months of minocycline treatment can modify cognitive and functional decline…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.